|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/18 | |
| A61K 39/00 |
| (11) | Number of the document | 3068791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14798760.6 |
| Date of filing the European patent application | 2014-11-06 | |
| (97) | Date of publication of the European application | 2016-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/073986 |
| Date | 2014-11-06 |
| (87) | Number | WO 2015/071177 |
| Date | 2015-05-21 |
| (30) | Number | Date | Country code |
| 201361904747 P | 2013-11-15 | US |
| (72) |
NORMAN, Carnley, US
SUDA, Eric, US
DOWLESS, Kayla, US
ASTIGARRAGA, Ruiz, US
BASTEK, Patrick, US
YANNONE, Vaishali, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES |
| REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES |